Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2005-02-03 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RIORGES (42153), Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE RIORGES : revenue, balance sheet and financial ratios
PHARMACIE DE RIORGES is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RIORGES (42153),
this company of category PME
shows in 2025 a net income positive of 181 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE RIORGES (SIREN 480908508)
Indicator
2025
2024
2023
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
181 353 €
216 716 €
209 381 €
217 657 €
96 405 €
162 307 €
159 420 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE RIORGES generates positive net income of 181 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 159 k€ -> 181 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
181 353 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
29.094%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.076%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE RIORGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2023
2024
2025
Debt ratio
15.067
13.261
340.134
162.874
53.685
39.125
29.094
Financial autonomy
68.415
70.871
17.806
31.119
51.377
58.753
63.076
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
29.092025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-7 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE RIORGES (29.09) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.08%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE RIORGES (63.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 246.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
246.267
Liquidity indicators evolution PHARMACIE DE RIORGES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2023
2024
2025
Liquidity ratio
173.571
190.626
206.971
280.694
160.216
233.425
246.267
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
246.272025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+34 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE RIORGES (246.27) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE RIORGES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE RIORGES is estimated at
2 880 813 €
(range 1 954 933€ - 4 520 393€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1954k€2880k€4520k€
2 880 813 €Range: 1 954 933€ - 4 520 393€
NAF 5 année 2025
Valuation method used
Net Income Multiple
181 353 €
×
15.9x
=2 880 814 €
Range: 1 954 934€ - 4 520 394€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE RIORGES with other companies in the same sector:
Frequently asked questions about PHARMACIE DE RIORGES
What is the revenue of PHARMACIE DE RIORGES ?
The revenue of PHARMACIE DE RIORGES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE RIORGES profitable?
Yes, PHARMACIE DE RIORGES generated a net profit of 181 k€ in 2025.
Where is the headquarters of PHARMACIE DE RIORGES ?
The headquarters of PHARMACIE DE RIORGES is located in RIORGES (42153), in the department Loire.
Where to find the tax return of PHARMACIE DE RIORGES ?
The tax return of PHARMACIE DE RIORGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE RIORGES operate?
PHARMACIE DE RIORGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart